Navidea Biopharma's (NAVB) Lymphoseek Receives Positive Option from EMA CHMP
Tweet Send to a Friend
Navidea Biopharma (AMEX: NAVB) announced that that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE